These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23907436)

  • 21. Role of calnexin in the ER quality control and productive folding of CFTR; differential effect of calnexin knockout on wild-type and DeltaF508 CFTR.
    Okiyoneda T; Niibori A; Harada K; Kohno T; Michalak M; Duszyk M; Wada I; Ikawa M; Shuto T; Suico MA; Kai H
    Biochim Biophys Acta; 2008 Sep; 1783(9):1585-94. PubMed ID: 18457676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cystic-fibrosis-associated ΔF508 mutation confers post-transcriptional destabilization on the C. elegans ABC transporter PGP-3.
    He L; Skirkanich J; Moronetti L; Lewis R; Lamitina T
    Dis Model Mech; 2012 Nov; 5(6):930-9. PubMed ID: 22569626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The short apical membrane half-life of rescued {Delta}F508-cystic fibrosis transmembrane conductance regulator (CFTR) results from accelerated endocytosis of {Delta}F508-CFTR in polarized human airway epithelial cells.
    Swiatecka-Urban A; Brown A; Moreau-Marquis S; Renuka J; Coutermarsh B; Barnaby R; Karlson KH; Flotte TR; Fukuda M; Langford GM; Stanton BA
    J Biol Chem; 2005 Nov; 280(44):36762-72. PubMed ID: 16131493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Base treatment corrects defects due to misfolding of mutant cystic fibrosis transmembrane conductance regulator.
    Namkung W; Kim KH; Lee MG
    Gastroenterology; 2005 Dec; 129(6):1979-90. PubMed ID: 16344066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribosomal frameshifting selectively modulates the assembly, function, and pharmacological rescue of a misfolded CFTR variant.
    Carmody PJ; Roushar FJ; Tedman A; Wang W; Herwig M; Kim M; McDonald EF; Noguera K; Wong-Roushar J; Poirier JL; Zelt NB; Pockrass BT; McKee AG; Kuntz CP; Raju SV; Plate L; Penn WD; Schlebach JP
    Proc Natl Acad Sci U S A; 2024 Oct; 121(42):e2414768121. PubMed ID: 39388263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of natural coumarin compounds that rescue defective DeltaF508-CFTR chloride channel gating.
    Xu LN; Na WL; Liu X; Hou SG; Lin S; Yang H; Ma TH
    Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):878-83. PubMed ID: 18430055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusional mobility of the cystic fibrosis transmembrane conductance regulator mutant, delta F508-CFTR, in the endoplasmic reticulum measured by photobleaching of GFP-CFTR chimeras.
    Haggie PM; Stanton BA; Verkman AS
    J Biol Chem; 2002 May; 277(19):16419-25. PubMed ID: 11877404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CFTR-Associated Ligand Arrests the Trafficking of the Mutant ΔF508 CFTR Channel in the ER Contributing to Cystic Fibrosis.
    Bergbower E; Boinot C; Sabirzhanova I; Guggino W; Cebotaru L
    Cell Physiol Biochem; 2018; 45(2):639-655. PubMed ID: 29402832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentiation of ΔF508- and G551D-CFTR-Mediated Cl- Current by Novel Hydroxypyrazolines.
    Park J; Khloya P; Seo Y; Kumar S; Lee HK; Jeon DK; Jo S; Sharma PK; Namkung W
    PLoS One; 2016; 11(2):e0149131. PubMed ID: 26863533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tgf-β1 inhibits Cftr biogenesis and prevents functional rescue of ΔF508-Cftr in primary differentiated human bronchial epithelial cells.
    Snodgrass SM; Cihil KM; Cornuet PK; Myerburg MM; Swiatecka-Urban A
    PLoS One; 2013; 8(5):e63167. PubMed ID: 23671668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human-mouse cystic fibrosis transmembrane conductance regulator (CFTR) chimeras identify regions that partially rescue CFTR-ΔF508 processing and alter its gating defect.
    Dong Q; Ostedgaard LS; Rogers C; Vermeer DW; Zhang Y; Welsh MJ
    Proc Natl Acad Sci U S A; 2012 Jan; 109(3):917-22. PubMed ID: 22210114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure of cAMP agonists to activate rescued deltaF508 CFTR in CFBE41o- airway epithelial monolayers.
    Bebok Z; Collawn JF; Wakefield J; Parker W; Li Y; Varga K; Sorscher EJ; Clancy JP
    J Physiol; 2005 Dec; 569(Pt 2):601-15. PubMed ID: 16210354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A defective flexible loop contributes to the processing and gating defects of the predominant cystic fibrosis-causing mutation.
    Chen X; Zhu S; Zhenin M; Xu W; Bose SJ; Wong MP; Leung GPH; Senderowitz H; Chen JH
    FASEB J; 2019 Apr; 33(4):5126-5142. PubMed ID: 30668920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chaperone displacement from mutant cystic fibrosis transmembrane conductance regulator restores its function in human airway epithelia.
    Sun F; Mi Z; Condliffe SB; Bertrand CA; Gong X; Lu X; Zhang R; Latoche JD; Pilewski JM; Robbins PD; Frizzell RA
    FASEB J; 2008 Sep; 22(9):3255-63. PubMed ID: 18556464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SYVN1, NEDD8, and FBXO2 Proteins Regulate ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitin-mediated Proteasomal Degradation.
    Ramachandran S; Osterhaus SR; Parekh KR; Jacobi AM; Behlke MA; McCray PB
    J Biol Chem; 2016 Dec; 291(49):25489-25504. PubMed ID: 27756846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 network.
    Lipecka J; Norez C; Bensalem N; Baudouin-Legros M; Planelles G; Becq F; Edelman A; Davezac N
    J Pharmacol Exp Ther; 2006 May; 317(2):500-5. PubMed ID: 16424149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational and temperature-sensitive stability defects of the delta F508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments.
    Sharma M; Benharouga M; Hu W; Lukacs GL
    J Biol Chem; 2001 Mar; 276(12):8942-50. PubMed ID: 11124952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis.
    Thibodeau PH; Richardson JM; Wang W; Millen L; Watson J; Mendoza JL; Du K; Fischman S; Senderowitz H; Lukacs GL; Kirk K; Thomas PJ
    J Biol Chem; 2010 Nov; 285(46):35825-35. PubMed ID: 20667826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global proteomic approach unmasks involvement of keratins 8 and 18 in the delivery of cystic fibrosis transmembrane conductance regulator (CFTR)/deltaF508-CFTR to the plasma membrane.
    Davezac N; Tondelier D; Lipecka J; Fanen P; Demaugre F; Debski J; Dadlez M; Schrattenholz A; Cahill MA; Edelman A
    Proteomics; 2004 Dec; 4(12):3833-44. PubMed ID: 15529338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial restoration of cAMP-stimulated CFTR chloride channel activity in DeltaF508 cells by deoxyspergualin.
    Jiang C; Fang SL; Xiao YF; O'Connor SP; Nadler SG; Lee DW; Jefferson DM; Kaplan JM; Smith AE; Cheng SH
    Am J Physiol; 1998 Jul; 275(1):C171-8. PubMed ID: 9688848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.